Author

L. L. W. Ishiwaka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Boehm· 1 shared A. Rostami· 1 shared B. Ciric· 1 shared D. Hwang· 1 shared G. Casella· 1 shared G.-X. Zhang· 1 shared H. Hakonarson· 1 shared J. P. Garifallou· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Boehm

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyProceedings of the National Academy of SciencesPeer-reviewedMar 30, 2022

CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.

D. Hwang, L. L. W. Ishiwaka, A. Boehm…·B. Ciric

This study shows that blocking CSF-1 reduces harmful myeloid cells in EAE without affecting beneficial ones, suggesting CSF-1 as a therapeutic target for MS.

DOI 10.1073/pnas.2111804119

mouseexperimental assay

𝕏 PostBluesky